I. Schousboe et Ms. Rasmussen, SYNCHRONIZED INHIBITION OF THE PHOSPHOLIPID MEDIATED AUTOACTIVATION OF FACTOR-XII IN PLASMA BY BETA(2)-GLYCOPROTEIN-I AND ANTI-BETA(2)-GLYCOPROTEIN-I, Thrombosis and haemostasis, 73(5), 1995, pp. 798-804
Lupus anticoagulants are a group of antibodies commonly found in patie
nts with autoimmune diseases such as systemic lupus erythematosus. Lup
us anticoagulants inhibit phospholipid dependent coagulation and may b
ind to negatively charged phospholipids. Recent studies have suggested
an association between anti-beta(2)-glycoprotein I and a lupus antico
agulant, whose activity is frequently dependent on the presence of bet
a(2)-glycoprotein I. Based on these observations, the effect of anti-b
eta(2)-glycoprotein I on the autoactivation of factor XII in plasma wa
s investigated. Autoactivation initiated by the presence of negatively
charged phospholipids, but not by sulfatide, was strongly inhibited b
y immunoaffinity purified anti-beta(2)-glycoprotein I, The dose-respon
se curve of anti-beta(2)-glycoprotein I was identical with that of a p
recipitating antibody, showing no inhibition at low and high antibody
dilutions and maximal inhibition at an intermediate dilution. At high
antibody concentrations, an increased rate of factor XIIa activation w
as observed. This increase was of the same magnitude as the decreased
rate observed in plasma supplemented with the same amount of beta(2)-g
lycoprotein I as in the plasma itself. This confirms the inhibitory ef
fect of beta(2)-GP-I on the contact activation and shows that inhibiti
on is effective on the autoactivation of factor XII in plasma, The inh
ibitory action of beta(2)-glycoprotein I was independent of the inhibi
tion caused by the anti-beta(2)-glycoprotein I/beta(2)-glycoprotein I
complex suggesting a synchronized inhibition of factor XII autoactivat
ion by beta(2)-glycoprotein I and anti-beta(2)-glycoprotein I. The inh
ibition caused by the antibody is suggested to be caused by a reduced
availability of negatively charged phospholipids due to the binding of
the anti-beta(2)-GP-I/beta(2)-GP-I complex, This complex may be a lup
us anticoagulant.